SECURITIES AND EXCHANGE COMMISSION
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
submitted an application under Rule
confidential treatment for information it excluded from
to a Form
March 18, 2013
Exhibit 10.22 was refiled with fewer redactions as Exhibit 10.2
to a Form 10
Q filed on May 7, 2013.
Based on representations by
s information qualifies as
confidential commercial or financial information under the Freedom of Information Act,
5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly
disclose it. Accordingly, excluded information from th
e following exhibit(s) will not be
released to the public for the time period(s) specified:
through June 30, 2020
For the Commission, by the Division of Corporation Finance, pursuant to
here is what I found - how it relates to insm not sure......
Investopedia explains 'Confidential Treatment Order - CTO'
Companies would typically seek a CTO in order to keep information that would otherwise put it at a disadvantage, a secret. For example, a company may apply for such an order to keep information regarding a pricing arrangement made with a partner, secret, since competitors finding out this information may go after the partner with a more competitive price.